The bioavailability and maturing clearance of doxapram in preterm infants-Reference-Cited by-同舟云学术

The bioavailability and maturing clearance of doxapram in preterm infants

Published:2020-07-22 Issue:5 Volume:89 Page:1268-1277
ISSN:0031-3998
Container-title:Pediatric Research
language:en
Short-container-title:Pediatr Res

Author:

Flint Robert B.^ORCID,Simons Sinno H. P.,Andriessen Peter,Liem Kian D.,Degraeuwe Pieter L. J.,Reiss Irwin K. M.,Ter Heine Rob,Engbers Aline G. J.,Koch Birgit C. P.,Groot Ronald de,Burger David M.,Knibbe Catherijne A. J.,Völler Swantje,Flint R. B.,Koch B. C. P.,Völler S.,Engbers A. G. J.,Knibbe C. A. J.,Andriessen P.,Degraeuwe P. L. J.,Liem K. D.,Simons S. H. P.,de Groot R.,Burger D. M.,Reiss I. K. M.,Burggraaf K.,Allegaert K.,Tibboel D.,van Dijk M.,

Publisher

Springer Science and Business Media LLC

Subject

Pediatrics, Perinatology and Child Health

Link

http://www.nature.com/articles/s41390-020-1037-9.pdf

Reference47 articles.

1. Poets, C. F. et al. Association between intermittent hypoxemia or bradycardia and late death or disability in extremely preterm infants. JAMA 314, 595–603 (2015).

2. Sawyer, T. et al. Improving neonatal intubation safety: a journey of a thousand miles. J. Neonatal Perinat. Med. 10, 125–131 (2017).

3. Sweet, D. G. et al. European Consensus Guidelines on the Management of Respiratory Distress Syndrome—2016 update. Neonatology 111, 107–125 (2017).

4. Morton, S. U. & Smith, V. C. Treatment options for apnoea of prematurity. Arch. Dis. Child Fetal Neonatal Ed. 101, F352–F356 (2016).

5. Schmidt, B. et al. Caffeine therapy for apnea of prematurity. N. Engl. J. Med. 354, 2112–2121 (2006).

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effects of doxapram and its potential interactions with K2P channels in experimental model preparations;Journal of Comparative Physiology A;2024-05-27

2. Farmakoterapia bezdechu u wcześniaczej subpopulacji neonatologicznej– możliwości terapeutyczne, implikacje farmakokinetyczne i wskazania do terapeutycznego monitorowania stężeniem leku we krwi;Prospects in Pharmaceutical Sciences;2024-05-08

3. When will the Glomerular Filtration Rate in Former Preterm Neonates Catch up with Their Term Peers?;Pharmaceutical Research;2024-03-12

4. Why population pharmacokinetic studies are instrumental to boost clinical research in neonates, and suggestions on how clinicians should assess these papers;Pediatric Research;2024-01-09

5. Doxapram versus placebo in preterm newborns: a study protocol for an international double blinded multicentre randomized controlled trial (DOXA-trial);Trials;2023-10-10